With morale at a low point, biotech and pharma CEOs are cautiously optimistic about the incoming Trump administration.

The next four years could be pivotal, with the potential to reshape the economy. Read why NSC and BCC stocks offer unique ...

Investors worry the hefty tariffs and mass deportations that Trump has proposed will reaccelerate inflation.

The list of global businessmen and CEOs sitting on the dais for the inauguration adds up to more than $12 trillion in market ...